Ospemifene is used for treating symptoms of urogenital atrophy, dyspareunia, and vaginal dryness associated with menopause. It was first introduced by Duchesnay Inc in its drug Osphena on Feb 26, 2013. 2 different companies have introduced drugs containing Ospemifene.

Ospemifene Patents

Given below is the list of patents protecting Ospemifene, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Osphena	US8642079	Solid formulations of ospemifene	Jul 09, 2028	Duchesnay
Osphena	US8236861	Method for enhancing the bioavailablity of ospemifene	Aug 11, 2026	Duchesnay
Osphena	US6245819	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause	Jul 21, 2025 (Expired)	Duchesnay
Osphena	US8470890	Method for enhancing the bioavailability of ospemifene	Feb 13, 2024 (Expired)	Duchesnay
Osphena	US8772353	Method for enhancing the bioavalability of ospemifene	Feb 13, 2024 (Expired)	Duchesnay
Osphena	US9241915	Method for enhancing the bioavailability of ospemifene	Feb 13, 2024 (Expired)	Duchesnay
Osphena	US9855224	Method for enhancing the bioavailability of ospemifene	Feb 13, 2024 (Expired)	Duchesnay
Osphena	US9566252	Method for the alleviation of dyspareunia in women	Nov 02, 2022 (Expired)	Duchesnay

Add above patents to watchlist

Ospemifene's Family Patents

Full family tree

Ospemifene Generic API Manufacturers

Only one generic application has been filed for Ospemifene.

Given below is the list of companies who have filed for Ospemifene generic, along with the locations of their manufacturing plants worldwide.